blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3370759

EP3370759 - COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND AN INTERFERON [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.02.2021
Database last updated on 13.11.2024
FormerExamination is in progress
Status updated on  14.06.2019
FormerRequest for examination was made
Status updated on  10.08.2018
FormerThe international publication has been made
Status updated on  13.05.2017
Formerunknown
Status updated on  11.11.2016
Most recent event   Tooltip12.02.2021Application deemed to be withdrawnpublished on 17.03.2021  [2021/11]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2018/37]
Inventor(s)01 / GAO, Lu
Building 5
No. 720
Cailun Road
Shanghai 201203 / CN
02 / NAJERA, Isabel
c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
03 / SHEN, Hong
Building 5
No. 720
Cailun Road
Shanghai 201203 / CN
04 / SHEN, Fang
Building 5
No. 720
Cailun Road
Shanghai 201203 / CN
05 / SHI, Liping
Building 5
No. 720
Cailun Road
Shanghai 201203 / CN
06 / WILDUM, Steffen
c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
07 / YANG, Guang
Building 5
No. 720
Cailun Road
Shanghai 201203 / CN
 [2018/37]
Representative(s)Sauer, Frank
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel / CH
[2018/37]
Application number, filing date16790332.731.10.2016
[2018/37]
WO2016EP76195
Priority number, dateWO2015CN9368803.11.2015         Original published format: PCT/CN2015/093688
[2018/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017076791
Date:11.05.2017
Language:EN
[2017/19]
Type: A1 Application with search report 
No.:EP3370759
Date:12.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 11.05.2017 takes the place of the publication of the European patent application.
[2018/37]
Search report(s)International search report - published on:EP11.05.2017
ClassificationIPC:A61K38/21, A61K31/506, A61P31/20
[2018/37]
CPC:
A61K31/506 (EP,KR,US); A61K31/5377 (EP,US); A61K38/212 (EP,KR,US);
A61P31/12 (EP,US); A61P31/22 (KR); A61K2300/00 (KR,US)
C-Set:
A61K31/506, A61K2300/00 (EP,US);
A61K38/212, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/37]
TitleGerman:KOMBINATIONSTHERAPIE EINES HBV-KAPSID-ANORDNUNGSINHIBITORS UND EINES INTERFERONS[2018/37]
English:COMBINATION THERAPY OF AN HBV CAPSID ASSEMBLY INHIBITOR AND AN INTERFERON[2018/37]
French:POLYTHÉRAPIE AU MOYEN D'UN INHIBITEUR D'ENSEMBLE CAPSIDE HBV ET D'UN INTERFÉRON[2018/37]
Entry into regional phase04.06.2018National basic fee paid 
04.06.2018Designation fee(s) paid 
04.06.2018Examination fee paid 
Examination procedure03.04.2018Date on which the examining division has become responsible
04.06.2018Examination requested  [2018/37]
18.12.2018Amendment by applicant (claims and/or description)
19.06.2019Despatch of a communication from the examining division (Time limit: M04)
21.10.2019Reply to a communication from the examining division
18.03.2020Despatch of a communication from the examining division (Time limit: M06)
29.09.2020Application deemed to be withdrawn, date of legal effect  [2021/11]
22.10.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/11]
Fees paidRenewal fee
08.10.2018Renewal fee patent year 03
11.10.2019Renewal fee patent year 04
09.10.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO0145712  (BAYER AG [DE], et al) [X] 1,12-14,16,27,31-33* Formula (I); page 3, lines 17-24; page 69, lines 11-18; page 80, lines 8-12;; example -; claim - *;
 [XDI]WO2014037480  (HOFFMANN LA ROCHE [CH], et al) [XD] 1,2,12-14,16,17,27-33 * Formula (I); page 87, lines 11-13;; example -; claim - * [I] 1-3,8-33;
 [XDI]WO2014184328  (HOFFMANN LA ROCHE [CH], et al) [XD] 1,4,12-14,16,17,27-33 * Formula (I); page 92, lines 9-11;; example -; claim - * [I] 1,4,5,8-33;
 [XDI]WO2015132276  (HOFFMANN LA ROCHE [CH], et al) [XD] 1,6,12-14,16,17,27-33 * Formula (I); page 58, lines 12-14;; example -; claim - * [I] 1,6-33
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.